Press Releases

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic

Serimmune Announces Achievement of Research Milestone in Discovery and Development Collaboration with Merck

Serimmune, a leader in understanding the functional antibody repertoire’s role in human disease, today announced that the company has received a research milestone payment from Merck (known as MSD outside the United States and Canada) under its ongoing discovery and development collaboration agreement.

Zymewire Launches Directory Of Drug Development Experts With Services Available To Fight COVID-19

Zymewire announces the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.

Noxopharm Investigating Potential COVID-19 Treatment

Noxopharm has identified a clinical trial opportunity that could help reduce the mortality rate of COVID-19.

FHI CLINICAL PROVIDING FULL-SERVICE CRO CAPABILITIES FOR CORONAVIRUS (COVID-19) CLINICAL TRIAL

FHI Clinical just announced it has partnered with Seattle-based Infectious Disease Research Institute (IDRI) to provide full-service CRO capabilities for an immunotherapy trial to combat moderate to severe cases of COVID-19.

OBVIOHEALTH LAUNCHES VIRTUAL COVID-19 SYMPTOMS & IMMUNE RESPONSE REGISTRY

Spring Bank Provides Update on Business Operations & Clinical Program Progress During COVID-19 Pandemic

The release announces an update on the company’s business operations in response to and as a result of the global COVID-19 pandemic; one of the announcements includes the Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned dose level.

WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic

The initiative launches with a weekly webinar series featuring WCG experts and guest panelists, with a focus on communicating emerging best practices in real time.

CluePoints´ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations

CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.

Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs

Creative Diagnostics Now Launches New Plant Pathogens Antibodies for Research Use

Creative Diagnostics launches high-quality plant pathogens antibodies for use in ELISA or related immunoassays.

Rho Experts Share Best Practices for Managing Risks in Clinical Trials

Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will outline and provide tips on the U.S. Food and Drug Administration (FDA)’s new sponsor responsibilities for managing risks in clinical trials in an upcoming webinar, “Managing the Risks of Implementing E6R2.” The webinar will take place on Wednesday, March 25, from 1-2 p.m. EST.

COVID-19 RAPID DETECTION – ICENI DIAGNOSTICS OFFERS NEW APPROACH

Coronavirus could be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, and distinguish between different viral strains

MR Solutions helps new ImPaKT facility become the best equipped containment laboratory in Canada

MR Solutions has installed a 3T PET-MR preclinical imaging system at Western University’s one of a kind ImPaKT Laboratory in Ontario.

Longhorn Vaccines & Diagnostics Encouraged by FDA to Help Solve Coronavirus Testing Bottleneck by Teaming PrimeStore MTM® with Diagnostic Developers

Coronavirus News: Longhorn’s PrimeStore MTM is the Only FDA Cleared Nucleic Transport Device that Inactivates Microbes Within the Device Allowing for Safe Transport and Testing

WCG’s WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies

WIRB-Copernicus IRB will give priority to the institutional review board (IRB) review of potentially life-saving COVID-19 vaccines and medications and waive their initial protocol review fees. 

Beijing University of Chinese Medicine collaborates with Elsevier to launch first branch of traditional Chinese medicine taxonomy

First taxonomy branch focuses on acupuncture, and will open up new resources to modern biomedical sciences as global interest in Traditional Chinese Medicine grows

Signant Health Appoints Ian Jennings as Chief Commercial Officer

Profacgen Updated Its Immunogenicity Assay for Drug Development

Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy in Clinical Research

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysis.